Search Results
Dr. Jedd Wolchok on Concurrent Ipilimumab and Nivolumab in Advanced Melanoma
CheckMate067 outcomes: Nivolumab plus ipilimumab in advanced melanoma
Dr. Wolchok on Weighing Risk and Benefit of Nivolumab/Ipilimumab Combo in Melanoma
Dr. Wolchok on the Safety Profile in CheckMate-067 in Melanoma
Dr. Wolchok Describes the Immunotherapy Ipilimumab
Success for ipilimumab and nivolumab combo in advanced melanoma
Dr. Jedd Wolchok Talks About a Recent Trial and its Effects on Untreated Melanoma Patients
Melanoma Immunotherapy with Dr. Jedd Wolchok
Dr. Wolchok on Updated CheckMate-067 Results for Melanoma
Dr. Kluger on a Phase I Trial of Concurrent Nivolumab and Ipilimumab for Advanced Melanoma
Nivolumab Plus Ipilimumab in Advanced Melanoma
Nivolumab alone or combined with ipilimumab vs IPI alone in advanced melanoma
